Mast cell-derived tumour necrosis factor is essential for allergic airway disease

European Respiratory Journal

Volumn 31, Issue 4, 2008, Pages 773-782

  Reuter, S ^a   Heinz, A ^a   Sieren, M ^a   Wiewrodt, R ^a   Gelfand, E W ^b   Stassen, M ^a   Buhl, R ^a   Taube, C ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Asthma; Immunology; Mast cell; Tumour necrosis factor

Indexed keywords

METHACHOLINE; TUMOR NECROSIS FACTOR; ALLERGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BONE MARROW CELL; CELLULAR IMMUNITY; CONTROLLED STUDY; GOBLET CELL; MAST CELL; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; ANIMAL; BRONCHUS HYPERREACTIVITY; DISEASE MODEL; IMMUNIZATION; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; GOBLET CELLS; IMMUNIZATION; INFLAMMATION; MAST CELLS; MICE; MICE, KNOCKOUT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42949139388     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00058907     Document Type: Article

References (55)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 344: 350-362.
2. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320: 271-277.
3. Peat JK, Tovey E, Toelle BG, et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996; 153: 141-146.
4. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699-1705.
5. Williams CM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000; 192: 455-462.
6. Yu M, Tsai M, Tam SY, Jones C, Zehnder J, Galli SJ. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 2006; 116: 1633-1641.
7. Taube C, Wei X, Swasey CH, et al. Mast cells, FcεRI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J Immunol 2004; 172: 6398-6406.
8. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6: 135-142.
9. Ott VL, Cambier JC, Kappler J, Marrack P, Swanson BJ. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat Immunol 2003; 4: 974-981.
10. Miyahara N, Swanson BJ, Takeda K, et al. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat Med 2004; 10: 865-869.
11. Taube C, Miyahara N, Ott V, et al. The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness. J Immunol 2006; 176: 3157-3164.
12. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990; 346: 274-276.
13. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381: 75-77.
14. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996; 381: 77-80.
15. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci USA 2005; 102: 6467-6472.
16. Nakae S, Suto H, Iikura M, et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006; 176: 2238-2248.
17. Suto H, Nakae S, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 2006; 176: 4102-4112.
18. Klein M, Klein-Hessling S, Palmetshofer A, et al. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J Immunol 2006; 177: 6667-6674.
19. Bergstresser PR, Tigelaar RE, Tharp MD. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 1984; 83: 214-218.
20. Bussolati G, Gugliotta P. Nonspecific staining of mast cells by avidin-biotin-peroxidase complexes (ABC). J Histochem Cytochem 1983; 31: 1419-1421.
21. Heib V, Becker M, Warger T, et al., Mast cells are crucial for early inflammation, migration of Langerhans cells and CTL responses following topical application of TLR7 ligand in mice. Blood 2007; 110: 946-953.
22. Wolters PJ, Mallen-St Clair J, Lewis CC, et al. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy 2005; 35: 82-88.
23. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101: 1614-1622.
24. Mehlhop PD, van de Rijn M, Goldberg AB, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A 1997; 94: 1344-1349.
25. Nogami M, Suko M, Okudaira H, et al. Experimental pulmonary eosinophilia in mice by Ascaris suum extract. Am Rev Respir Dis 1990; 141: 1289-1295.
26. Takeda K, Hamelmann E, Joetham A, et al. Development of eosinophilic airway inflammation and airway hyper-responsiveness in mast cell-deficient mice. J Exp Med 1997; 186: 449-454.
27. Kraneveld AD, van der Kleij HP, Kool M, et al. Key role for mast cells in nonatopic asthma. J Immunol 2002; 169: 2044-2053.
28. Kung TT, Stelts D, Zurcher JA, et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 1995; 12: 404-409.
29. Ogawa K, Kaminuma O, Kikkawa H, et al. Primary role of CD4+ T cells and supplemental role of mast cells in allergic pulmonary eosinophilia. Int Arch Allergy Immunol 1999; 120: Suppl. 1, 15-18.
30. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005; 167: 835-848.
31. Stassen M, Hültner L, Schmitt E. Classical and alternative pathways of mast cell activation. Crit Rev Immunol 2002; 22: 115-140.
32. Kinet JP. The high-affinity IgE receptor (FceRI): from physiology to pathology. Annu Rev Immunol 1999; 17: 931-972.
33. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002; 2: 773-786.
34. Grünig G, Warnock M, Wakil AE, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-2263.
35. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258-2261.
36. Taube C, Duez C, Cui ZH, et al. The role of IL-13 in established allergic airway disease. J Immunol 2002; 169: 6482-6489.
37. Benyon RC, Bissonnette EY, Befus AD. Tumor necrosis factor-α dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies. J Immunol 1991; 147: 2253-2258.
38. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor-α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991; 88: 4220-4224.
39. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992; 258: 1957-1959.
40. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381: 75-77.
41. von Stebut E, Metz M, Milon G, Knop J, Maurer M. Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell-derived TNFa. Blood 2003; 101: 210-215.
42. Rijnierse A, Koster AS, Nijkamp FP, Kraneveld AD. TNF-α is crucial for the development of mast cell-dependent colitis in mice. Am J Physiol Gastrointest Liver Physiol 2006; 291: G969-G976.
43. Biedermann T, Kneilling M, Mailhammer R, et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000; 192: 1441-1452.
44. van Houwelingen AH, Kool M, de Jager SC, et al. Mast cell-derived TNF-α primes sensory nerve endings in a pulmonary hypersensitivity reaction. J Immunol 2002; 168: 5297-5302.
45. Casale TB, Costa JJ, Galli SJ. TNF-α is important in human lung allergic reactions. Am J Respir Cell Mol Biol 1996; 15: 35-44.
46. Busse PJ, Zhang TF, Srivastava K, et al. Chronic exposure to TNF-α increases airway mucus gene expression in vivo. J Allergy Clin Immunol 2005; 116: 1256-1263.
47. Choi IW, Sun K, Kim YS, et al. TNF-α induces the latephase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation. J Allergy Clin Immunol 2005; 116: 537-543.
48. Nakae S, Lunderius C, Ho LH, Schäfer B, Tsai M, Galli SJ. TNF can contribute to multiple features of ovalbumin-induced allergic inflammation of the airways in mice. J Allergy Clin Immunol 2007; 119: 680-686.
49. Kim YS, Ko HM, Kang NI, et al. Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-α in a murine model of asthma. Eur J Immunol 2007; 37: 1107-1115.
50. Nakae S, Ho LH, Yu M, et al. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J Allergy Clin Immunol 2007; 120: 48-55.
51. Erin EM, Leaker BR, Nicholson GC, et al. The effects of a monoclonal antibody directed against tumor necrosis factor-α in asthma. Am J Respir Crit Care Med 2006; 174: 753-762.
52. Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor-α in refractory asthma. N Engl J Med 2006; 354: 697-708.
53. Howarth PH, Babu KS, Arshad HS, et al. Tumour necrosis factor (TNF-α) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005; 60: 1012-1018.
54. van Rijt LS, Jung S, Kleinjan A, et al. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005; 201: 981-991.
55. Jawdat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 2004; 173: 5275-5282.